Literature DB >> 21402102

A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.

Jonathan H Sherman1, Gerard T Redpath, Jan A Redick, Benjamin W Purow, Edward R Laws, John A Jane, Mark E Shaffrey, Isa M Hussaini.   

Abstract

Isolation of glioblastoma stem cells requires incubation of tumor cells in a neural stem cell media. Neurospheres containing these glioblastoma stem cells are formed after approximately a five-day period. These cells can then be analyzed for the presence of stem cell markers. Immunofluorescence staining for these markers can serve as a valuable tool for analyzing the intact neurosphere directly in stem cell media. Here we present the use of a novel fixative (1,4-benzoquinone) for immunoflourescence staining of neurospheres.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402102      PMCID: PMC3126626          DOI: 10.1016/j.jneumeth.2011.03.003

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  13 in total

1.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

2.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

Authors:  Dagmar Beier; Peter Hau; Martin Proescholdt; Annette Lohmeier; Jörg Wischhusen; Peter J Oefner; Ludwig Aigner; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

3.  An immunofluorescent method for a specific demonstration of granulocytes and some of their proteins (ECP and CCP).

Authors:  K Fredens; R Dahl; P Venge
Journal:  Histochemistry       Date:  1986

4.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

Authors:  Myung Jin Son; Kevin Woolard; Do-Hyun Nam; Jeongwu Lee; Howard A Fine
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

5.  Stem cell marker CD133 affects clinical outcome in glioma patients.

Authors:  Felix Zeppernick; Rezvan Ahmadi; Benito Campos; Christine Dictus; Burkhard M Helmke; Natalia Becker; Peter Lichter; Andreas Unterberg; Bernhard Radlwimmer; Christel C Herold-Mende
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

6.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

Authors:  Patrick C Hermann; Stephan L Huber; Tanja Herrler; Alexandra Aicher; Joachim W Ellwart; Markus Guba; Christiane J Bruns; Christopher Heeschen
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

7.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

8.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

9.  Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.

Authors:  Mick D Brown; Paul E Gilmore; Claire A Hart; Joanne D Samuel; Vijay A C Ramani; Nicholas J George; Noel W Clarke
Journal:  Prostate       Date:  2007-09-15       Impact factor: 4.104

10.  CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.

Authors:  S Maeda; H Shinchi; H Kurahara; Y Mataki; K Maemura; M Sato; S Natsugoe; T Aikou; S Takao
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

View more
  1 in total

1.  TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.

Authors:  K Di; M E Linskey; D A Bota
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.